Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Induction Chemotherapy Followed by Concurrent Chemoradiation vs Concurrent Chemoradiation in Locally Advanced Cervical Cancer
ChiCTR2500110542Phase 3Not yet recruiting
- Sponsor
- Sohag University
- Start
- Oct 2025
- Modality
- Small Molecules, DNA Intercalators/Alkylators → Nucleic Acid-Directed Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of paclitaxel, cisplatin and carboplatin in Cervical Cancer (CC) (2 arms), sponsored by Sohag University. Primary endpoints: Clinical response rate at the end of induction chemotherapy and Overall survival rate. Planned start Oct 2025; status: not yet recruiting.
02
Drugs
paclitaxelcisplatincarboplatin
03
Conditions
Cervical Cancer (CC)
Beyond the preview
Go deeper on ChiCTR2500110542.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2500110542.